Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rubens Study: Pardoprunox Monotherapy in Early Parkinson's Disease
2008-004943-12Phase 2Completed
- Sponsor
- Solvay Pharmaceuticals
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pardoprunox in Parkinson's disease (PD) (3 arms), sponsored by Solvay Pharmaceuticals. Primary endpoint: Change in UPDRS part 3 score at Week 4/endpoint. Started Oct 2008; status: completed.
02
Drugs
pardoprunox
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2008-004943-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004943-12.